Related by context. All words. (Click for frequent words.) 84 Relieve Depression 65 Sequenced Treatment Alternatives 64 FOR AN OPEN 63 STRATEGY FOR AN OPEN 62 Oral Fingolimod 62 Hematological Cancers 62 THEO TORONTO 61 Adjuvant Treatment 61 Non Responders 61 See CLINICAL PHARMACOLOGY 61 Showed Significant 61 Depressive Symptoms 61 Pharmacologic 61 Schizophrenia Treatment 61 Subgroup Analysis 61 Sleep Disturbances 60 Clinical Outcome 60 Systematic Treatment 60 undergoing Percutaneous Coronary 60 PATRICK CORRIGAN TORONTO 60 Relapsing Multiple Sclerosis 60 #:#-#,# CrossRef Medline [002] 60 ORDER OF EASTERN 60 Fibromyalgia Pain 60 Intervention Effectiveness 60 HEY ROCK 59 #:#-#,# CrossRef Medline [001] 59 Antiplatelet 59 Helps Relieve 59 Treatment Reduces 59 Bipolar Depression 59 Inhaled Corticosteroids 59 Suicidality 59 Hospital Acquired Pneumonia 59 venlafaxine XR 59 ACE Inhibitors 59 Diamyd Medical Diamyd 59 Fecal Incontinence 59 Treatment Resistant 59 Statin Drugs 59 Cognitive Behavior Therapy 58 Watchful Waiting 58 Research www. elsevier.com 58 Complicated Skin 58 Metastatic Prostate Cancer 58 Demonstrates Positive 58 Demonstrates Sustained 58 Skin Lesions 58 Iron Deficiency Anemia 58 Enlarged Prostate 58 Combo Therapy 58 Inhaled Nitric Oxide 58 Adolescent Substance Abuse 58 Therapeutic Intervention 58 Aripiprazole 58 Substance Dependence 58 mu opioid agonist analgesics 58 Ischemic Stroke 58 Psychotic Disorders 58 Invasive Fungal Infections 57 Phase IIa Clinical Trial 57 Randomized Clinical Trials 57 Prolongs Survival 57 Escitalopram 57 Therapy Improves 57 Plaque Psoriasis 57 Orthostatic Hypotension 57 Peginterferon 57 Tiotropium 57 Demonstrate Significant 57 Generalized Anxiety Disorder 57 Bipolar Mania 57 interdenominational peer 57 Lowering Blood Pressure 57 Clostridium difficile Infection 57 Severely Obese 57 Treatment Naive Patients 57 Unstable Angina 57 Long Term Efficacy 57 Diagnostic Criteria 57 PHYSICAL THERAPY 57 Effective Treatments 57 Follicular Lymphoma 57 #:#-#,# [002] 57 Decompensated Heart Failure 57 Clinical Antipsychotic Trials 57 Endovascular Repair 57 Often Misdiagnosed 57 venlafaxine Effexor 57 Anxiety Depression 57 Clinical Evaluation 57 Therapy Reduces 57 Study Evaluating 57 Reduces Pain 57 Migraine Headache 57 Fungal Infections 57 CAN SHE 57 Prevent Stroke 57 Non Invasive Treatment 57 Combination Treatment 57 Causes Symptoms 57 Prospective Randomized 57 Relapse Prevention 57 Dry Powder Inhalers 57 Hepatitis C Treatment 57 RE MODEL 57 Paliperidone ER 57 Cognitive Behavioral Therapy 57 Interpersonal psychotherapy 57 Gene Mutation Linked 57 Juvenile Idiopathic Arthritis 56 Insulin Sensitivity 56 Lupus Drug 56 Helps Smokers Quit 56 Betaferon R 56 Magnetic Stimulation 56 Genes Associated 56 Meets Primary Endpoint 56 Fewer Side Effects 56 generalized anxiety disorder GAD 56 Community Acquired Pneumonia 56 Treating Chronic 56 Phase 2a Trial 56 Risk Stratification 56 EMRG VIO 56 Percutaneous Tibial Nerve Stimulation 56 TMC# C# 56 Dose Ranging 56 Generalized Anxiety Disorder GAD 56 Depressive Disorders 56 Anti Depressant 56 Coronary Artery Calcium 56 Gout Drug 56 Uterine Cancer 56 Physician Insights 56 Ziprasidone 56 M Models Excluded 56 Lamotrigine 56 paroxetine Paxil 56 CENTERS FOR 56 Antipsychotic 56 Pre Cancerous 56 Acne Scars 56 Acne Drug 56 Randomized controlled 56 Postmenopausal Osteoporosis 56 Vaginal Gel 56 Detection Evaluation 56 Services #:#-#,# Abstract 56 Sleep Disturbance 56 Study Shows Significant 56 Currency Majors Technical 56 Placebo Controlled Study 56 Treatment Outcome 56 Chronic Heart Failure 56 Breast Density 56 Randomized Controlled Trial 56 Levels Linked 56 Hormone Refractory Prostate Cancer 56 Protease Inhibitor 56 #:#-#,# [001] 56 Female Sexual Arousal 56 Interpersonal Psychotherapy 56 Artery Disease 56 Childhood Trauma 56 Meta Analysis 56 Genes Predict 56 Treating Depression 56 Refractory Angina 56 Newly Diagnosed Multiple Myeloma 56 Antipsychotic Drugs 56 Hormone Receptor Positive 56 Adjuvant Chemotherapy 56 Appears Safe 56 Improves Outcomes 56 duloxetine Cymbalta 56 Chronic Obstructive Lung 56 Elderly Patients 56 ADHD Medication 56 Recurrent Breast Cancer 56 Orally Active 56 Node Positive 55 Boosts Survival 55 Osteoarthritis Pain 55 Capsules CII 55 Systematic Review 55 Adult ADHD 55 Less Invasive 55 Preterm Labor 55 Epilepsy Drug 55 leukopenia pancytopenia thrombocytopenia 55 Panic Disorder 55 Smoking Linked 55 Allergic Rhinitis 55 Valvular Heart Disease 55 number NCT# ClinicalTrials.gov 55 Multiple Ascending Dose 55 Lowers Blood Pressure 55 HALTS 55 Cognitive Problems 55 Osteoporosis Drug 55 Obese Teens 55 Chronic Lung 55 Anti Tumor 55 Lipid Lowering 55 Antidepressant Use 55 Heart Failure Patients 55 antiepileptics 55 Improve Patient Outcomes 55 NSABP B 55 HER2 Positive 55 Childhood Asthma 55 Cardiovascular Radiology 55 Phase 2b Clinical Trial 55 DPNP 55 sertraline Zoloft 55 Aggressive Drug Evaluation 55 Colorectal Screening 55 Psychodynamic Psychotherapy 55 Phase Ib Clinical Trial 55 Acute Coronary Syndromes 55 CLINICAL PHARMACOLOGY 55 Social Phobia 55 Opioid Addiction 55 Initiated Phase 55 Drug Coated Stents 55 Severe Asthma 55 Antidepressants Linked 55 Lymphoma Patients 55 Calcium Vitamin D 55 Migraine Headaches 55 Co Occurring 55 Opioid Use 55 Male Contraceptive 55 Secondary Hyperparathyroidism 55 Postmenopausal 55 tiagabine 55 Tyrosine Kinase Inhibitor 55 Patients Receiving 55 Rare Genetic 55 opioid naive 55 Rheumatoid Arthritis Patients 55 Sertraline 55 Functional Outcomes 55 Critically Ill Patients 55 Refractory Hodgkin Lymphoma 55 Desvenlafaxine 55 Diabetic Foot Ulcer 55 Newly Diagnosed Breast Cancer 55 Phase IIb Trial 55 Hormonal Contraceptives 55 insulin glulisine 55 Corticosteroid 55 Shown Effective 55 Versus Placebo 55 ARIXTRA R 55 Irritable Bowel 55 Rhinosinusitis 55 Depression Anxiety 55 Breast Exams 55 Fondaparinux 55 Comorbid 55 Novel Compound 55 Prenatal Alcohol 55 Bare Metal Stent 55 Pegylated Liposomal Doxorubicin 55 Synaptic Plasticity 55 Investigational Treatment 55 Overactive Bladder 55 Breast Cancer Recurrence 55 phase IIIb 55 Post Operative 55 KEEPS HIS 55 Statistically Significant 55 INVEGA ® 55 Cardiac Resynchronization 55 Cocaine Addiction 55 Adjunctive Therapy 55 FDA Approves Drug 55 citalopram Celexa 55 Cognitive Impairment 55 Posaconazole 55 Intervention Effectiveness CATIE 55 Venous Thromboembolism 55 Laryngeal Cancer 55 Zicam Extreme 55 Whooping Cough Vaccine 55 schizophrenia schizoaffective disorder 55 Gastric Cancer 55 acute subacute 55 Patients Suffering 55 Prognostic Factors 55 Postherpetic Neuralgia 54 Unfractionated Heparin 54 FORCE PROTECTION 54 MEVACOR 54 Asthma Treatment 54 Pain Relievers 54 Pharmacodynamic 54 Knee Osteoarthritis 54 Disease Progression 54 Arthritis Aquatic 54 Premature Birth 54 Treated Patients 54 Teva Provides Update 54 Slow Progression 54 Bone Marrow Cells 54 Retinal Vein Occlusion 54 Content Outline 54 Shows Promise Against 54 Violent Environments 54 Gene Variation 54 Blood Pressure Medication 54 Cognitive Deficits 54 Menstrual Pain 54 Pediatric Patients 54 Montgomery Åsberg Depression 54 icatibant 54 Blepharospasm 54 Mesothelioma Treatment 54 FOR WELL BEING 54 Major Depressive Disorder 54 Controlled Study 54 Shows Efficacy 54 Antidepressant Treatment 54 Cardiotoxicity 54 Embolization 54 Tumor Response 54 Breast Cancer Treatment 54 EMRG POL 54 aripiprazole 54 Node Negative 54 Excessive Sweating 54 Pediatric Psychopharmacology 54 Nebulized 54 Adjunctive 54 Randomized Study 54 Greenspan Warns 54 Abatacept 54 Uterine Fibroids 54 SCHIZOPHRENIA DISORDERS SUPPORT GROUP 54 Osteoporosis Drugs 54 Vertebral Fracture 54 Catapres 54 Bipolar Disorder STEP BD 54 CNS Disorders 54 Estrogen Therapy 54 Beta Blocker 54 See WARNINGS 54 antidepressant monotherapy 54 Stress Hormone 54 Renal Function 54 Diabetic Kidney Disease 54 Nesiritide 54 Generic Versions 54 Calcium Supplements 54 RN LVN CNA 54 Clinical Trial Evaluating 54 Menopausal Symptoms 54 Nicotine Addiction 54 Inhaled Steroids 54 symptomatic hyponatremia 54 COPD Exacerbations 54 Relapsing Remitting Multiple Sclerosis 54 Genetic Variation 54 Pneumococcal Vaccine 54 Diabetic Neuropathic Pain 54 Schizoaffective Disorder 54 buproprion 54 Phase 2b Study 54 Malignant Glioma 54 gives SLGN neutral 54 Bone Fractures 54 Obesity Linked 54 Hepatitis C Infection 54 Renal Impairment 54 IS SET FOR 54 Drug Regimen 54 COPEGUS R 54 Chemotherapeutic Agents 54 Therapeutic Efficacy 54 Newly Diagnosed 54 Bone Metastases 54 Brain Shrinkage 54 Demonstrated Significant 54 Blood Pressure Drug 54 Efficacy Trial 54 Demonstrates Efficacy 54 Generic Accutane 54 J Clin Psychiatry 54 Soft Tissue Sarcoma 54 Lung Cancer Survival 54 Psychiatric Illness 54 Patients Treated With 54 Erectile Dysfunction Drug 54 Osteoporosis Treatment 54 Severe Sepsis 54 Reformers Unanimous Addictions 54 raloxifene Evista 54 Eszopiclone 54 MEDICATIONS 54 Selective serotonin reuptake inhibitors 54 FDA Approvals 54 Binge Eating 54 Study Reinforces 54 Etanercept 54 Treatment Shows Promise 54 Neuroendocrine Tumors 54 Preclinical Models 54 Nilotinib 54 Hypertensive Patients 54 Phase IIb Clinical Trial 54 Postmenopausal Women 54 PROGRAM COORDINATOR 54 Brief Psychiatric 54 Randomized Placebo Controlled 54 Drug Combo 54 Peripheral Arterial 54 Muscle Wasting 54 Single Dose 54 Psychiatric Disorders 54 BREEDERS CROWN 54 Successfully Completes Phase 54 Iron Deficiency 54 Healthy Eating Habits 54 Multicenter Trial 54 Naive Patients 54 MORE THAN TREAS 54 Electrical Stimulation 54 tricyclic antidepressants TCAs 54 Ischaemic 53 Reduces Mortality 53 Platinol ® 53 Carotid Artery Stenting 53 Angiotensin Converting Enzyme 53 Advanced Prostate Cancer 53 #:#-#,# [003] 53 Tanespimycin 53 LUFKIN STATE SCHOOL 53 Zoloft sertraline 53 Transdermal Patch 53 Reduces Breast Cancer 53 Carotid Stenting 53 Healthbeat Report 53 Septic Shock 53 Urine Test 53 Harsh Interrogation 53 Study Shows Promise 53 AT SANDOWN 53 Hsp# Inhibitor 53 SCHOOL LUNCH 53 Unresectable 53 Heroin Addiction 53 Aortic Stenosis 53 Vitamin D Supplementation 53 Transdermal Delivery 53 ADVANCE REVIEW 53 Eye Diseases 53 paroxetine sertraline 53 Chemotherapy Induced 53 Pediatric Physical Therapy 53 Recurrent Ovarian Cancer 53 Partial Onset Seizures 53 Psychiatric Evaluation 53 Phase III Trial 53 Vertebral Compression Fracture 53 Genetic Markers 53 Aortic Aneurysm 53 Cyclophosphamide 53 Liver Metastases 53 Antidepressant Drug 53 Corneal Transplant 53 Retinal Diseases 53 Carotid Revascularization Endarterectomy vs. 53 EFFEXOR XR 53 Nonsurgical 53 Renal Cell Carcinoma 53 Strongly Linked 53 Oral Calcitonin 53 Lowers Risk 53 Neoadjuvant Chemotherapy 53 Rheumatoid Arthritis Drug 53 SEX ATTACK 53 Atomoxetine 53 CLEARED OVER 53 Pertuzumab 53 cialis herbal 53 Abilify aripiprazole 53 Arch Neurol 53 rheumatoid arthritis osteoarthritis ankylosing 53 Inflammatory Pain 53 Abusive Relationships 53 Recurrent Glioblastoma 53 attention-deficit/hyperactivity 53 Stent Coating 53 Acute Attacks 53 Subtypes 53 Novel Inhibitor 53 R lenalidomide 53 Growth Hormone Deficiency 53 Premenopausal Women 53 Metastatic Pancreatic Cancer 53 Hepatic Encephalopathy 53 THE SHARPIE FONT 53 Test Detects 53 Opioid Induced Constipation 53 Symptom Relief 53 GOES SOLO 53 Commonly Used 53 Denufosol 53 CARING FOR 53 Decitabine 53 Disord 53 No Setup Fees 53 Urinary Incontinence 53 Psychodynamic 53 Hedge Fund Replication 53 STEP BD 53 Text Revision 53 Geodon ziprasidone 53 Systolic Hypertension 53 Cholesterol Screening 53 polyarticular 53 Venlafaxine 53 Prophylaxis 53 Anticoagulant 53 Childhood Vaccines 53 Stimulation Therapy 53 CALERIE 53 Chronic Liver Disease 53 acting injectable formulation 53 Hepatitis C Genotype 53 VINCE 'S 53 Lung Cancer Trial 53 Potentially Fatal 53 SLAIN IN 53 Accelerated Partial Breast Irradiation 53 Rilonacept 53 Sustained Reduction 53 Improves Survival 53 Inflammatory Arthritis 53 GETS INTO 53 Neurological Devices 53 PEDIATRIC 53 Adjuvant Therapy 53 divalproex sodium 53 Heel Pain 53 Cognitive Behavioural Therapy 53 Enoxaparin 53 Nonalcoholic Fatty Liver Disease 53 Hormone Replacement 53 Opioid Dependence 53 Mimetics 53 IND Application 53 Leukemias 53 Prostate Cancer Patients 53 Mycophenolate Mofetil 53 Colorectal Adenomas 53 REYATAZ ® 53 efavirenz EFV 53 HDAC Inhibitor 53 Meta Analyses 53 Phase III multicenter 53 desvenlafaxine succinate 53 Posttraumatic 53 Mitral Regurgitation 53 Hip Fractures 53 Protein Linked 53 emotional lability 53 'S EFFORTS TO 53 Menopause Symptoms 53 Tricyclic antidepressants 53 interpersonal psychotherapy 53 clonidine hydrochloride 53 Shows Statistically Significant 53 AGILECT ® 53 Gestational Diabetes 53 Metabolic Disorder 53 Antiangiogenic 53 Makes Recommendations 53 Diabetic Neuropathy 53 Guidelines Issued 53 Schizophrenia Drug 53 IN TRIBUTE TO 53 Therapy Helps 53 FDA Okays 53 Fluoxetine 53 Antipsychotic Drug 53 Demonstrates Potent 53 Migraine Treatment 53 Chronic Stress 53 #-# Full Text 53 ST Segment Elevation 53 Brain Scans 53 Asthma Attacks 53 Chemoradiation 52 Heterozygous Familial Hypercholesterolemia 52 Fracture Risk 52 HHS Substance Abuse 52 Maternal Depression 52 Oral Anticoagulants 52 interpersonal psychotherapy IPT 52 Suicidal Behavior 52 Previously Treated 52 Daptomycin 52 Ovarian Cancer Treatment 52 Sinus Infections 52 Poniard Pharmaceuticals Announces 52 NUTRITIONAL 52 #:#-#,# CrossRef 52 YEAR OLD DAUGHTER 52 Anticonvulsant 52 Ischemic 52 Glycemic Control 52 Weight Loss Supplement 52 Prescription Painkiller 52 Attention-Deficit/Hyperactivity Disorder 52 Chronic Lymphocytic Leukemia 52 Prostate Cancer Survival 52 Atypical Antipsychotics 52 IS EXPECTED TO PRODUCE 52 Bone Fracture 52 Autologous Stem Cell Transplantation 52 Blood Thinning 52 Dupuytren Contracture 52 Castration Resistant Prostate Cancer 52 Clinical Efficacy 52 Renal Insufficiency 52 pimozide 52 Cognitive Dysfunction 52 gives XEC 52 Home Hemodialysis 52 BENICAR HCT 52 Androgen Deprivation Therapy 52 Cardiovascular Disease Risk 52 Sustained Efficacy 52 Intervention Trial 52 gives WLK neutral 52 Brain Stimulation 52 Prostate Screening 52 Crit Rev 52 Improving Patient 52 Risperdal Zyprexa 52 Drug Prevents 52 Prostate Cancer Treatment 52 Abciximab 52 Chronic Wounds 52 Advanced Melanoma 52 Immunomodulatory 52 Endometrial Ablation 52 Blood Cancers 52 Sipuleucel T 52 Genes Influence 52 Gene Linked 52 Major Depressive Disorder MDD 52 DE STRESS 52 Improve Diagnosis 52 Mindfulness Based Cognitive Therapy 52 FOR THIS RACE 52 SUBOXONE 52 Posttraumatic Stress 52 Lung Cancer Drug 52 TEARS FOR 52 SAPHRIS 52 J Consult Clin 52 IACI neutral 52 hematological parameters 52 Texas Medication Algorithm 52 Remissions 52 EVALUATE 52 Conduct Disorder 52 Bosutinib 52 Cellular Immunotherapy 52 Carotid Endarterectomy 52 topiramate Topamax 52 dual endothelin receptor antagonist 52 Dose Response 52 Phase 2a Clinical Trial 52 Low Dose 52 Bulimia Nervosa 52 Pediatric Asthma 52 Cognitive behavioral therapy 52 Muscle Function 52 Injection Site 52 Medication Adherence 52 Prolongs Life 52 Autoimmune Disease 52 somatostatin analog 52 BENICAR 52 headache abdominal pain 52 Adverse Effects 52 Thromboembolic 52 Migraine Sufferers 52 Immunotherapeutic 52 serotonin norepinephrine reuptake inhibitor 52 Application Deadline Extended 52 Pregnancy Outcomes 52 Lung Injury 52 DR MC# 52 Cutaneous T 52 Degenerative Disc Disease 52 Cilostazol 52 Comorbidity 52 GISSI 52 Neural Stem Cells 52 Differential Diagnosis 52 Chronic Hepatitis B 52 Sustained Release 52 Various Types 52 Acute Stroke 52 Dementia Diagnosis 52 orally inhaled migraine 52 Bronchiectasis 52 Clinical Trial Data 52 Bronchopulmonary Dysplasia 52 DOV neutral 52 Genes Linked 52 Further Validates 52 Carbamazepine 52 Lifestyle Changes 52 Acute Ischemic Stroke 52 Thyroid Hormone 52 Obese Patients 52 Dual Diagnosis 52 Thymosin Beta 4 52 neuroleptic 52 Pre Exposure Prophylaxis 52 gives AVY 52 FLOW OF 52 Neoadjuvant 52 Cognitive Behavioral 52 Exacerbations 52 Monotherapy 52 Psychiatric Epidemiology 52 Visceral Fat 52 Hepatitis C Virus Infection 52 CIMZIA R 52 Telik Announces 52 Stress Testing 52 Behavioral Disorders 52 Arterial Disease 52 HEADS BACK TO 52 Advanced Pancreatic Cancer 52 Periodontal Disease 52 Anthracycline 52 Not Otherwise Specified 52 Device Helps 52 Data Suggest 52 Chronic Cough 52 Neovascular Age Related Macular 52 Cognitive Abilities 52 RAMP UP 52 Endocrinol 52 amisulpride 52 HOLS 52 Patient Focused 52 Endometrial Cancer 52 Depression Bipolar 52 J Virol 52 Sandostatin R 52 Comorbidities 52 Bacterial Vaginosis 52 Brain Metastases 52 JWN neutral 52 Fixed Dose 52 YEARS FOR 52 EHR Adoption 52 Menopausal Women 52 Analytical Tool 52 Treating Heart Failure 52 Ecallantide 52 Buprenorphine Treatment 52 gives UVV 52 WESTERN ASSET 52 Antiviral Therapy 52 DSM IV Axis 52 Calcium Intake 52 Breast Cancer Metastasis 52 ALCOHOLISM 52 Anemia Drug 52 Anti Tumor Activity 52 COURT OVER 52 Screening Questionnaire 52 VITAL SIGNS 52 TO WED 52 Spinal Fusion 52 Hyperkalemia 52 Peanut Allergy 52 External Beam 52 APTIVUS r 52 Transplant Patients 52 guanfacine extended release 52 Skin Structure Infections 52 Quetiapine 52 LOOKS GREAT 52 Anticancer Drugs 52 Effectively Treats 52 Drug Candidate 52 Colon Cleansing 52 Chickenpox Vaccine 52 Soy Isoflavones 52 Lung Cancer Patients 52 Non inferiority 52 B Cell Malignancies 52 Who Underwent 52 Osteoarthritis Patients 52 Arthritis Sufferers 52 Acute Liver Failure 52 Bone Marrow Transplants 52 Novel Therapeutic 52 Am J Geriatr 52 BY CHRISTINA 52 Patients Undergoing 52 Electroconvulsive Therapy 52 Montelukast 52 Initiates Clinical Trial 52 Organ Rejection 51 ergot derivatives 51 Chemotherapy Improves 51 Racial Disparities 51 Edinburgh Postnatal Depression 51 Statin Therapy 51 Valve Replacement 51 Paraplatin ® 51 Peer Reviewed Medical 51 medroxyprogesterone acetate 51 www.a star.edu.sg 51 Self Efficacy 51 Mercury Fillings 51 Atopic Dermatitis 51 Clinician Administered PTSD 51 Predict Prostate Cancer 51 Radiation Induced 51 pregabalin Lyrica 51 Chronic Lyme Disease 51 Lung Cancers 51 ON TUESDAYS 51 PUSHING FOR 51 Clinically Proven 51 Initiates Phase III 51 Risedronate 51 Prostate Cancer Vaccine 51 rufinamide 51 Glaucoma Treatment 51 Hematological 51 olanzapine LAI 51 Targeted Therapy 51 #:#-#,# Medline 51 Pegylated Interferon 51 fludarabine cyclophosphamide 51 Short Stature 51 Generalised Anxiety Disorder 51 Drug Shows Promise 51 Genetic Variations 51 Sleep Duration 51 Kidney Function 51 Eases Pain 51 Neurocognitive 51 Sociodemographic 51 Cholesterol Drugs 51 aripiprazole Abilify 51 iShares Diversified 51 tryptophan depletion 51 Herbal Supplements 51 Coronary Artery Bypass Graft 51 Long Term Outcomes 51 Frontotemporal Dementia 51 Gastroesophageal Reflux Disease 51 Genetic Defect 51 SALISBURY SCHOOL 51 Psychological Effects 51 PREZISTA ritonavir 51 reuptake inhibitor 51 Chronic Pelvic Pain 51 Lupus Nephritis 51 HPV Vaccine Gardasil 51 Venous thromboembolism 51 CNS depressant 51 PICKED FOR 51 Cognitive Function 51 REUTERS Claudia Daut 51 Synthetic Peptide 51 DOG TRAINING 51 Aranesp Therapy 51 Psychiatric Diagnosis 51 Infill Housing 51 Secondhand Smoke Exposure 51 Antihypertensive 51 Aggressive Behavior 51 Renal Anemia 51 including cyclosporine methotrexate 51 Nutritional Status 51 Trigeminal Neuralgia 51 MoxDuo TM IR 51 Stem Cell Treatment 51 Alternative Approaches 51 oropharyngeal candidiasis OPC 51 mGluR2 positive 51 Late Onset 51 Cost Effectiveness 51 Rheumatoid 51 Antiarrhythmic 51 Phase III Clinical Trial 51 Treatment Regimen 51 Depression NARSAD 51 Benign Prostatic Hyperplasia 51 GRATEFUL FOR 51 Ascites 51 Copay 51 Sleep Problems 51 Blood Clot Risk 51 VIIBRYD 51 Arch Pediatr Adolesc Med 51 RISPERDAL ® 51 DRIVING W OA LICENSE 51 Servicer Ratings 51 ELOXATIN 51 Lung Cancer Risk 51 Breast Tumor 51 Protein Involved 51 Treat Anemia 51 TERRIFIED OF 51 Pill Splitting 51 GlaxoSmithKline Plc Paxil 51 Cardiovascular Outcomes 51 Excessive Sleepiness 51 Behavior Therapy 51 Ovarian Cancer Risk 51 Hospitalization Rates 51 Cancer AACR NCI 51 Illiquidity Risk 51 Glucosamine Chondroitin Arthritis 51 Dialectical Behavior Therapy 51 Patellofemoral 51 Pain Meds 51 Equetro 51 Sexual Assualt 51 Therapy Shows Promise 51 BXP neutral 51 STORMS INTO 51 RECORD LEVELS 51 C1 Inhibitor 51 Intravenous Formulation 51 WOMEN 'S SUPPORT GROUP 51 Investigational Agent 51 HER2 Positive Breast Cancer 51 Morbidity Mortality 51 Childhood Immunizations 51 RELUCTANT TO 51 CorVue ™ 51 Restless Legs 51 Clinical Practice Guideline 51 Renal Cancer 51 II Clinical Trial 51 Thrombolysis 51 Surgical Treatment 51 Methadone Maintenance 51 Alternative Treatments 51 Op Ed Contributors 51 Inflammatory Markers 51 Hip Fracture Risk 51 Improve Survival 51 Investigator Initiated 51 Genetic Mutation 51 Adjuvant Breast Cancer 51 Psoriasis Drug 51 Mental Disorders DSM IV 51 Pneumonia Vaccine 51 reflux disease GERD 51 AUD USD -#.# 51 Testosterone Patch 51 depression schizophrenia bipolar 51 BRIGHTEST 51 Lifestyle Intervention 51 hepatic insufficiency 51 Progressive Multifocal Leukoencephalopathy 51 Depression Study TADS 51 Novel Oral 51 Novel Approaches 51 Smallpox Vaccination 51 Inflammatory Disease 51 Asthma COPD 51 Regimens 51 Bosentan 51 FDA Warns Against 51 Abstinence Programs 51 Dr. Wayne Drevets 51 AvalonBay Communities Announces 51 Silicone Breast Implants 51 Chronic Constipation 51 Chronic Sinusitis 51 Pressure Ulcer Prevention 51 DEFENDS HIS 51 LOSES HIS 51 conjugated equine estrogens 51 Viral Suppression 51 TAGS PGOV 51 Benazepril 51 Educational Settings